Coloplast Organic Growth Better Than Expected, but Margins Still Lag Consensus

• (PLX AI) - Colplast Q3 EBIT margin 30% vs. estimate 30.8%.
• • Outlook FY organic growth 6-7%
• • Outlook FY capex DKK 1,200 million
• • Outlook FY EBIT margin 28-29%
• • Q3 organic growth 8% vs. estimate 6.6%
• • Q3 revenue DKK 5,849 million vs. estimate DKK 5,723 million
• • Q3 EBIT DKK 1,741 million vs. estimate DKK 1,761 million
• • Q3 net income DKK 1,289 million vs. estimate DKK 1,249 million